Company intelligence / Profile preview

Perceptive

Ownership: Private
Development stage: Commercial

Overview

Perceptive has supported over 11,000 clinical trials globally with more than 800 regulatory approvals enabled. The company delivers high-quality data for preclinical to late-phase studies using advanced imaging and eClinical technologies. Their expertise spans over five decades in the industry.

Modalities: small moleculesbiologicsradiopharmaceuticalsadvanced therapies
Industry: Contract Research Organization

Partnerships

AstraZenecaBiogenIpsenMerck & Co.Moderna

Beyond the preview

Go deeper on Perceptive.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perceptive.

Explore the full profile